Integrated BioPharma (OTCMKTS:INBP) Releases Earnings Results

Integrated BioPharma (OTCMKTS:INBP) issued its quarterly earnings results on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, Zacks reports. Integrated BioPharma had a negative return on equity of 1.02% and a negative net margin of 0.40%.The business had revenue of $10.11 million for the quarter.

Integrated BioPharma Price Performance

Shares of INBP stock remained flat at $0.25 on Friday. The company had a trading volume of 2,032 shares, compared to its average volume of 10,378. Integrated BioPharma has a 52-week low of $0.21 and a 52-week high of $0.42. The company has a market cap of $7.75 million, a PE ratio of -12.50 and a beta of 0.41. The business has a 50 day moving average of $0.28 and a two-hundred day moving average of $0.31.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.